NC100100, a new echo contrast agent for the assessment of myocardial perfusion—safety and comparison with technetium‐99m sestamibi single‐photon emission computed tomography in a randomized multicenter study

Background and hypothesis: Myocardial contrast echocardiography using second‐generation agents has been proposed to study myocardial perfusion. A placebo‐controlled, multi‐center trial was conducted to evaluate the safety, optimal dose, and imaging mode for NC100100, a novel intravenous second‐gener...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Binder, Thomas, Assayag, Patrick, Baer, Frank, Flachskampf, Frank, Kamp, Otto, Nienaber, Christoph, Nihoyannopoulos, Petros, Pi érard, Luc, Steg, Gabriel, Vanoverschelde, Jean‐Louis, Wouw, Poll Van Der, Meland, Nils, Marelli, Claudio, Lindvall, Kaj
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2009
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656247/
https://ncbi.nlm.nih.gov/pubmed/10198737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960220405
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars